BFC Planning’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
Other funds holding ATOS
BFC Planning's ATOS Position: Q3 2026 in Review
BFC Planning opened a new position in Atossa Therapeutics (ATOS) in Q3 2026: 124 shares worth $242. The stake represents ﹤0.01% of the portfolio and ranks #3339 among its holdings.
29 funds tracked by Wall St. Rank hold ATOS as of Q3 2026.
- BFC Planning held 124 shares of Atossa Therapeutics worth $242 as of Q3 2026.
- Atossa Therapeutics was a new BFC Planning position in Q3 2026.
- Atossa Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3339 holding.
- 29 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.